Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effect of Single Ascending Doses of CC-92480 in Healthy Subjects
Clinical trial NCT03803644 · COMPLETED
Trial details
- NCT number
- NCT03803644
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-21
- Primary completion
- 2019-05-28
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.